MARS and Prometheus: Our Clinical Experience in Acute Chronic Liver Failure

Transplantation Proceedings

Volumn 40, Issue 4, 2008, Pages 1169-1171

  Faenza, S ^a   Baraldi, O ^a   Bernardi, M ^a   Bolondi, L ^a   Coli, L ^a   Cucchetti, A ^a   Donati, G ^a   Gozzetti, F ^a   Lauro, A ^a   Mancini, E ^a   Pinna, A D ^a   Piscaglia, F ^a   Rasciti, L ^a   Ravaioli, M ^a   Ruggeri, G ^a   Santoro, A ^a   Stefoni, S ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALBUMIN DIALYSIS; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL PROTOCOL; CONVALESCENCE; HEMODIALYSIS PATIENT; HOSPITAL ADMISSION; HUMAN; LIVER FAILURE; LIVER GRAFT; LIVER SUPPORT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; BLOOD COAGULATION DISORDERS; CHRONIC DISEASE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER FAILURE; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MIDDLE AGED; SORPTION DETOXIFICATION; WAITING LISTS;

EID: 44749095116     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.03.069     Document Type: Article

References (11)

1. Bauer M., Winning J., and Kortgen A. Liver failure. Curr Opin Anaesthesiol 18 (2005) 111
2. Sen S., Davies N.A., Mookerjee R.P., et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transplant 10 (2004) 1109
3. Santoro A., Mancini E., Ferramosca E., et al. Liver support systems. Contrib Nephrol 156 (2007) 396
4. Magosso E., Ursino M., Coli L., et al. A modeling study of bilirubin kinetcs during Molecular Adsorbent Recirculating System sessions. Artif Organs 30 (2006) 285
5. Stadibauer V., Krisper P., Beuers U., et al. Removal of bile acids by two different extracorporeal liver support systems in acute-onchronic liver failure. ASAIO J 53 (2007) 187
6. Donati G., Piscaglia F., Coli L., et al. Acute systemic, splanchnic and renal haemodynamic changes induced by molecular adsorbent recirculating system (MARS) treatment in patients with end-stage cirrhosis. Aliment Pharmacol Ther 26 (2007) 717
7. Stadbauer V., Krisper P., Aigner R., et al. Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure. Crit Care 10 (2006) R169
8. Brown Jr. R.S. MARS preconditioning for living donor liver transplantation: panacea or placebo?. Liver Int 25 (2005) 692
9. Wai C.T., Lim S., Aung M., et al. MARS: a futile tool in centres without active liver transplant support. Liver Int 27 (2007) 69
10. Wiesner R., McDiarmid S., Kamath P.S., et al. MELD and PELD: Application of survival models to liver allocation. Liver Transpl 7 (2001) 567
11. Liu J.P., Gluud L.L., Als-Nielsen B., et al. Artificial and bioartificial support systems for liver failure. Cochrane Database of Systematic Reviews 1 (2004) cdoo3628